SCHEMBL13488374

SCHEMBL13488374

CCOC(=O)C1=C(NCc2ccc(Cl)cc2Cl)CCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
CXCR3 P49682 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ADORA1 P30542 1/20 0.41
ROCK2 O75116 1/20 0.41
CHEK2 O96017 1/20 0.41
PRKACA P17612 1/20 0.41
RPS6KA3 P51812 1/20 0.41
PAK1 Q13153 1/20 0.41
ROCK1 Q13464 1/20 0.41
DYRK1A Q13627 1/20 0.41
PRKD2 Q9BZL6 1/20 0.41
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
MAPT P10636 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
ALOX15 P16050 1/20 0.40
ESR2 Q92731 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13488441 0.94 CXCR3 (0.43) ALDH1A1CXCR3MEN1KMT2AADORA1
SCHEMBL5727368 0.81 CASP3 (0.49) MEN1KMT2AADORA1SMN1; SMN2NPSR1
SCHEMBL20765935 0.81 KMT2A (0.46) ALDH1A1MEN1KMT2AADORA1TP53
SCHEMBL17629577 0.78 MAPT (0.42) ALDH1A1MEN1KMT2AADORA1MAPT
SCHEMBL5731017 0.76 CHRM5 (0.48) ALDH1A1MEN1KMT2AADORA1TP53
SCHEMBL5927238 0.75 ADORA1 (0.46) ALDH1A1MEN1KMT2AADORA1MAPT
SCHEMBL4318911 0.74 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AROCK2CHEK2
SCHEMBL13780301 0.74 DPP4 (0.45) ALDH1A1MEN1KMT2AROCK2CHEK2
SCHEMBL26647798 0.74 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AADORA1MAPT
SCHEMBL3197591 0.73 SLC6A3 (0.55) ADORA1MAPTTP53POLBESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8445481-B2 Scaffold-diversified pyrrolidinone derivatives and their use THE UNIVERSITY OF CHICAGO (US) 2013-05-21 US disclosed
US-8445481-B2 Scaffold-diversified pyrrolidinone derivatives and their use THE UNIVERSITY OF CHICAGO (US) 2013-05-21 US disclosed
US-20100035892-A1 METHOD FOR ASSEMBLING HIGH-PURITY CHEMICAL LIBRARIES, COMPOUNDS SUPPRESSING ACETYL COENZYME A CARBOXYLASE ACTIVITIES DISCOVERED BY SAME THE UNIVERSITY OF CHICAGO 2010-02-11 US disclosed
US-20100035892-A1 METHOD FOR ASSEMBLING HIGH-PURITY CHEMICAL LIBRARIES, COMPOUNDS SUPPRESSING ACETYL COENZYME A CARBOXYLASE ACTIVITIES DISCOVERED BY SAME THE UNIVERSITY OF CHICAGO 2010-02-11 US disclosed
WO-2008103382-A1 METHOD FOR ASSEMBLING HIGH-PURITY CHEMICAL LIBRARIES, COMPOUNDS SUPPRESSING ACETYL COENZYME A CARBOXYLASE ACTIVITIES DISCOVERED BY SAME KOZMIN SERGEY (US) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035892-A1 METHOD FOR ASSEMBLING HIGH-PURITY CHEMICAL LIBRARIES, COMPOUNDS SUPPRESSING ACETYL COENZYME A CARBOXYLASE ACTIVITIES DISCOVERED BY SAME ACACA, COASY, ACACB ALDH1A1 219/4885CXCR3 2468/4885MEN1 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.